Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Wade Grindle

Wade Grindle

Dr Wade Grindle is an experienced, fellowship trained, board-certified anesthesiologist, with an MD degree from UC San Diego.
Medtronic's Management Presents at Cowen Health Care Conference (Transcript): Medtronic Inc. (MDT) Cowen Healt... http://seekingalpha.com/article...
Aspen Pharmacare Offers Very Expensive Developing World Growth: By Stephen Simpson:Aspen Pharmacare (APNHY.PK)... http://seekingalpha.com/article...
MEI Pharma's CEO Presents at Cowen and Company 33rd Annual Health Care Conference - Conference Call Transcript... http://seekingalpha.com/article...
Disclosure and offer: Who protects the patient’s interests?: When the Lexington, Kentucky VA Medic... http://www.kevinmd.com/blog... #Healthcare
A Deal For Pozen's PA Could Send Shares Soaring: By Jason Napodano: By Jason Napodano, CFA On March 6, 2013... http://seekingalpha.com/article...
A Top Biotech Stock To Own In 2013 Expected To Quadruple: By Steve Rosenman: Seven months have elapsed since t... http://seekingalpha.com/article...
Nordion Management Discusses Q1 2013 Results - Earnings Call Transcript: Nordion (NDZ) Q1 2013 Earnings Call M... http://seekingalpha.com/article...
Fundamentals (The Nitty Gritty Of Investing): By The Tenacious Trader: Catch me a fish and I will eat today,... http://seekingalpha.com/article...
Herbalife's Tragic Flaw: Understanding Inventory Loading: Herbalife's (HLF) compensation scheme encourages inv... http://seekingalpha.com/article...
Eli Lilly: A Bull Run Corroborated By Its Fundamentals: By Ed Liston: On 28th of February Eli Lilly (LLY) was ... http://seekingalpha.com/article...
Biotech Stocks With Recent Developments: 3 To Consider, 1 To Avoid: By Brian L. Wilson: Biotech Stocks With ... http://seekingalpha.com/article...
Celebrex Ruling Is A Windfall For Pfizer: ByDeep Dives:Pfizer, Inc. (PFE) reported earlier today that it had r... http://seekingalpha.com/article...
Vivus Changes Qsymia Price Again - What Investors Need To Know: By Spencer Osborne: Vivus (VVUS), the company ... http://seekingalpha.com/article...
Endocyte, Inc. CEO Discusses at Cowen & Company 33rd Annual Health Care Conference - Conference Call Transcrip... http://seekingalpha.com/article...
ImmunoCellular Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript: ImmunoCellular Therapeu... http://seekingalpha.com/article...
Alpha Pro Tech's Management Discusses Q4 2012 Results - Earnings Call Transcript: Alpha Pro Tech, Ltd. (APT) Q... http://seekingalpha.com/article...
MELA Sciences Management Discusses Q4 2012 Results - Earnings Call Transcript: MELA Sciences (MELA) Q4 2012 Ea... http://seekingalpha.com/article...
Taking A Close Look At Bristol-Myers' Dividend: By Valuentum: Dividend growth investing is lots of fun, especi... http://seekingalpha.com/article...
Kythera Biopharmaceuticals' CEO Presents at Cowen Health Care Conference (Transcript): Kythera Biopharmaceutic... http://seekingalpha.com/article...
MAKO: 'Less Bad' Is Good: ByMaltzberger:After posting disappointing results for most of last year, MAKO Surgic... http://seekingalpha.com/article...
Regulus Therapeutics' Management Presents at Cowen and Company 33rd Annual Healthcare Conference (Transcript):... http://seekingalpha.com/article...
Pfizer's Stake In HIV Breakthrough: ByDeep Dives:Pfizer, Inc. (PFE) appears to have missed out on a significan... http://seekingalpha.com/article...
ChemoCentryx's CEO Presents at Cowen & Company 33rd Annual Health Care Conference (Transcript): ChemoCentryx, ... http://seekingalpha.com/article...
Trius: Establishing A Compelling Case For Tedizolid: By David Sobek:Trius Therapeutics (TSRX) will soon be rep... http://seekingalpha.com/article...
A Look At 3 Obesity Stocks: By BuySellShort:There is no question that obesity is one of the leading causes of de... http://seekingalpha.com/article...
Which Of The Top 8 Drug Makers Is Most Attractive To Dividend Investors: By Arie Goren:Major drug manufacturer... http://seekingalpha.com/article...
After Successful ALS Phase I, Neuralstem Branches Out: ByHilltop Warrior:Back in October, when I first encount... http://seekingalpha.com/article...
Several Catalysts Behind My Decision To Establish A Position In Biogen Idec: ByHeather Ingrassia:On Monday, Ma... http://seekingalpha.com/article...
Investors React To Arena's Q4: By Spencer Osborne: Arena (ARNA) held its Q4 and 2012 results conference call p... http://seekingalpha.com/article...
Amgen Benefits From Affymax Recall: By Peter Geschek: Recall Medical advance has its ups and downs, risks an... http://seekingalpha.com/article...
Other ways to read this feed:Feed readerFacebook